dihexa pnb-0408 human trial | c-Met/HGFR dihexa clinical trials status What

Recent studies have revealed that calpain-2 conditional knockout mice are protected against the pathological consequences of repeated mild TBI and that genetic deletion or pharmaceutical inhibition of calpain-2 prevented alterations in the subcellular localization of TDP-43

fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder

Folate Receptor Alpha Autoantibodies: A more recent discovery of autoantibodies that target the Folate Receptor Alpha has been implicated in children with ASD

That said, it is not a guaranteed solution, and responsible use requires education, medical oversight, and realistic expectations

[59:04] Dr

You are now ready to inject